skip to Main Content

Synthetic Lung Surfactant

Technology relates to an inexpensive and extremely effective synthetic lung surfactant, which has the potential to save the lives of babies, children and adults suffering with any of a range of respiratory and lung ailments. Synthetic formulation consisting of a combination of phospholipids and synthetic peptides which may be administered in liquid form or nebulised/aerosolised.

Patent Application Number:: WO2011/104621

For more details about technology: Click Here

Modulators Of Histone Acetyltransferase

Invention relates to the field of novel anticancer agents. Compounds shown in figure are useful for the treatment of cancer, AIDS, HIV infections and asthma.

Patent Application Number: 7332629

For more details about technology: Click Here

Stereo-Selective Preparation Of 3-Hydroxy-3-Phenylpropionitrile

Technology relates to a Chemoenzymatic process for the stereoselective preparation of both (R) and (S) enantiomers of 3-hydroxy-3-phenylpropanenitrile, useful as a key intermediate for synthesis of (S)-Fluoxetine, (R)-Tomoxetine and cognant compounds.

 

Patent Application Number: WO/2002/057475, Granted Indian and UK Patent and pending JP Patent.

For more details about technology: Click Here

Polyisoprenylated Benzophenones As Inhibitors Of Histone Acetyltransferases

Invention relates to Polyisoprenylated benzophenones and their isomers as inhibitors of histone acetyltransferases. These compounds are useful as biological switching molecules for evaluating the role of p300 and PCAF in cellular functions and also may be useful as new chemical entities for the development of anticancer drugs.

Patent Application Number: 7402706

For more details about technology: Click Here

Stereo-Selective Preparation Of 3-Hydroxy-3-(2-Thienyl) Propanenitrile

Technology relates to a Chemoenzymatic process for the stereoselective preparation of both enantiomers of 3-hydroxy-3-(2-thienyl) propanenitrile, which are optically pure intermediates for the synthesis of both enantiomers of duloxetine in high enantiomeric excess.

 

Patent Number: 7045341, Granted Indian and EP Patent.

For more details about technology: Click here

Lutein From Oleoresin

Invention relates to a Process for isolating, purifying and formulating commercial grade lutein paste from oleoresin. Process comprises dissolving oleoresin in alcohol to obtain xanthophylls esters , hydrolyzing with base, quenching, drying ester layer and finally mixing the obtained lutein crystals with non-water soluble fractions to obtain stable lutein paste. Lutein thus prepared can be made stable during storage without use of chemical additives and also available at viable prices.

Patent Application Number:7179930

For more details about technology: Click here

Back To Top